Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Micro-dissected tumor tissues (MDTs) are maintained alive on chip for several days and show promising results for personalized medicine applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MDTs were cultured and kept alive on the chip in a low-shear stress environment for extended time periods (over one week).”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [198]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [114]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [114]
In the citing paper
“Due to the direct use of tumor tissue, this approach includes many key components in tumor such as heterogeneous cell types and abnormal blood vessel networks.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [155]
In the citing paper
“In addition, the various types of cells in tumor tissues were all treated as tumor cells in these studies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [155]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Compilation of Henry's law constants (version 4.0) for water as solvent
Sander, R. (2015) · Atmospheric Chemistry and Physics · doi:10.5194/acp-15-4399-2015 · Cited by 2,873
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
Research works printed but not linked: 4
- Vaupel, 1987, Cancer Res., 47, 3496
- Koch, 1978, Br. J. Cancer, Suppl., 3, 163
- H. Lamb , Hydrodynamics, Cambridge University Press, 6th ed., 1994
- Francis, 1933, J. Appl. Phys., 4, 403
Cited by
Items 101–188 of 188
Zhou, L., Liu, L., Chang, M. A., Ma, C., Chen, W., & Chen, P. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115064 · Cited by 22
Integrated Microphysiological Systems: Transferable Organ Models and Recirculating Flow
Renggli, K., Rousset, N., Lohasz, C., Nguyen, O. T. P., & Hierlemann, A. R. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900018 · Cited by 22
Self-citationMicro/nanofluidic devices for drug delivery
Kashaninejad, N., Moradi, E., & Moghadas, H. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.018 · Cited by 23
“and personalized medicine due to the current oncology drug development pipeline.(41,42) In one research, microdissected tissues (MDT) were obtained from live tumor tissue and were segmented reproducibly to submillimeter sections and cultured on an MDT-on-chip (Fig.”
MethodRadiotherapy on-chip: microfluidics for translational radiation oncology
Chermat, R., Ziaee, M., Mak, D. Y., Refet-Mollof, E., Rodier, F., Wong, P., Carrier, J., Kamio, Y., & Gervais, T. (2022) · Lab on a Chip · doi:10.1039/d2lc00177b · Cited by 22
Self-citationEngineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
He, Y., Liu, D., Ling, A., Han, Z., Cui, J., Cheng, J., Feng, Y., Liu, W., Gong, W., Xia, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07789-5 · Cited by 19
Filion, R., St‐Georges‐Robillard, A., Chaudoir, H., Ritch, S. J., Ndongo, M., Chua, X. Y., Laurent, E., Mes‐Masson, A., Ajji, A., & Gervais, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-16863-z · Cited by 18
Self-citationRismanian, M., Saidi, M. S., & Kashaninejad, N. (2020) · Journal of Flow Chemistry · doi:10.1007/s41981-020-00104-7 · Cited by 17
A Microfluidic Device for Long‐Term Maintenance of Organotypic Liver Cultures
de Hoyos‐Vega, J. M., Hong, H. J., Loutherback, K., Stybayeva, G., & Revzin, A. (2022) · Advanced Materials Technologies · doi:10.1002/admt.202201121 · Cited by 19
Cancer-on-a-chip for Drug Screening
Lee, I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190206235233 · Cited by 17
Abrego, C. J. G., Zaunz, S., Toprakhisar, B., Subramani, R., Deschaume, O., Jooken, S., Bajaj, M. S., Ramón, H., Verfaillie, C. M., Bartic, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176367 · Cited by 17
“For sectioning the tissue, an agarose gel was used according to an established methodology [48,49].”
MethodChristensen, M. G., Cawthorne, C., Dyer, C. E., Greenman, J., & Pamme, N. (2021) · Microfluidics and Nanofluidics · doi:10.1007/s10404-021-02434-x · Cited by 16
Advancements in microfluidics for skin cosmetic screening
Hu, N., Cheng, K., Zhang, S., Liu, S., Wang, L., Du, X., Li, Y., & Li, C. (2023) · The Analyst · doi:10.1039/d2an01716d · Cited by 18
Chuaychob, S., Lyu, R., Tanaka, M., Haginiwa, A., Kitada, A., Nakamura, T., & Yokokawa, R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312472121 · Cited by 15
“…cell culture and microfluidic technology enables the design of a specific tumoral microenvironment suitable for elucidating cell responses to the environment (8), the evaluation of drug efficacy in drug screening (9–11), and the test of therapeutic applications (12) prior to human clinical trials.”
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
Manzano-Muñoz, A., Yeste, J., Ortega, M. A., Martín, F., López, A., Rosell, J., Castro, S., Serrano, C., Samitier, J., Ramón‐Azcón, J., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00333-0 · Cited by 16
Shin, S., Choi, Y., Jang, W., Batjargal, U., Ha, G., Kang, R., Park, S., Kim, M., Zhang, Y. S., Kim, H., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101741 · Cited by 22
de Hoyos‐Vega, J. M., Gonzalez‐Suarez, A. M., & Garcia-Cordero, J. L. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-0156-0 · Cited by 13
Thread as a Low-Cost Material for Microfluidic Assays on Intact Tumor Slices
Rumaner, M., Horowitz, L. F., Ovadya, A., & Folch, A. (2019) · Micromachines · doi:10.3390/mi10070481 · Cited by 13
“(2) Microdissected tumor tissue in culture involves the mechanical fragmentation of biopsies which can cause local tissue damage, but has recently been shown to preserve some key pathways for immunotherapy [14,15].”
BackgroundDorrigiv, D., Goyette, P.-A., St‐Georges‐Robillard, A., Mes‐Masson, A., & Gervais, T. (2023) · Cancers · doi:10.3390/cancers15041060 · Cited by 12
Self-citationBrennen, W. N., Magnen, C. L., Karkampouna, S., Anselmino, N., Bock, N., Choo, N., Clark, A. K., Coleman, I. M., Dolgos, R., Ferguson, A. M., et al. (2024) · The Prostate · doi:10.1002/pros.24682 · Cited by 13
“61,62 These systems could also model biological interfaces and mechanical forces to mimic the TME and dynamic changes in various factors, including drugs, over time.”
BackgroundBrasino, D. S. K., Speese, S. D., Schilling, K. J., Schutt, C. E., & Barton, M. C. (2024) · Advanced Science · doi:10.1002/advs.202309220 · Cited by 18
Inventions and Innovations in Preclinical Platforms for Cancer Research
Moshksayan, K., Kashaninejad, N., & Saidi, M. S. (2018) · Inventions · doi:10.3390/inventions3030043 · Cited by 13
Brachytherapy on-a-chip: a clinically-relevant approach for radiotherapy testing in 3d biology
Chermat, R., Refet-Mollof, E., Kamio, Y., Carrier, J., Wong, P., & Gervais, T. (2024) · Lab on a Chip · doi:10.1039/d4lc00032c · Cited by 11
Self-citationLockhart, E. J., Horowitz, L. F., Rodriguez, A. D., Zhu, S., Nguyen, T., Mehrabi, M., Gujral, T. S., & Folch, A. (2024) · Lab on a Chip · doi:10.1039/d4lc00016a · Cited by 11
Low-cost robotic manipulation of live microtissues for cancer drug testing
Stepanov, I., Gottshall, N. R., Ahmadianyazdi, A., Sinha, D., Lockhart, E. J., Nguyen, T. N. H., Hassan, S., Horowitz, L. F., Yeung, R. S. W., Gujral, T. S., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads1631 · Cited by 11
Markoski, A., Wong, I. Y., & Borenstein, J. T. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.646441 · Cited by 9
Surface Optimization and Design Adaptation toward Spheroid Formation On-Chip
Azizipour, N., Avazpour, R., Sawan, M., Ajji, A., & Rosenzweig, D. H. (2022) · Sensors · doi:10.3390/s22093191 · Cited by 12
“Laminar flow in microfluidic channels provided protection of spheroids from the shear stress caused by exchange of medium, while the diffusion-based mass exchange is quick enough to effectively remove cellular waste and provide nutrition for spheroids [15,28,32].”
BackgroundLu, J., Huang, Y., Hu, S., Xuzhan, L., Huang, Y., Wu, B., Zhao, C., Huang, J., Tan, B., Zhao, B., et al. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118791 · Cited by 7
A mechanobiological mathematical model of liver metabolism
Nikmaneshi, M. R., Firoozabadi, B., & Munn, L. L. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27451 · Cited by 8
“…simulate oxygen metabolism of in vitro cultures to determine inactive hypoxic regions under different morphological and environmental conditions (Astolfi et al., 2016; Bhise et al., 2016; Buchwald, 2009; Cho et al., 2007; Kagawa, Matsuura, Shimizu, & Tsuneda, 2015; Khakpour et al., 2017;…”
Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response
Komar, Z. M., van Gent, D. C., & Chakrabarty, S. (2023) · Current Protocols · doi:10.1002/cpz1.693 · Cited by 7
“Earlier studies describing similar OoC devices had only a single flow (top or bottom) or a perfusion system for media flow (Astolfi et al., 2016; Horowitz et al., 2020; Kennedy et al., 2019; Rodriguez et al., 2020; Shirure and George, 2017).”
BackgroundBarry, A., Samuel, S. F., Hosni, I., Moursi, A., Feugere, L., Sennett, C., Deepak, S., Achawal, S., Rajaraman, C., Iles, A., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00204g · Cited by 8
St‐Georges‐Robillard, A., Cahuzac, M., Péant, B., Fleury, H., Lateef, M. A., Ricard, A., Sauriol, S. A., Leblond, F., Mes‐Masson, A., & Gervais, T. (2019) · Integrative Biology · doi:10.1093/intbio/zyz012 · Cited by 8
Self-citationDesign and engineering of multiorgan systems
Renggli, K., & Frey, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00012-7 · Cited by 8
Microfluidic perfusion modulates growth and motor neuron differentiation of stem cell aggregates
Jackson, E., Schaefer, A. W., McDevitt, T. C., & Lu, H. (2020) · The Analyst · doi:10.1039/d0an00491j · Cited by 9
Joshi, P., do Nascimento, H. S., Kang, S., Lee, M., Vanga, M. G., Lee, S., Ku, B., Miranda, M. D. S., & Lee, M. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28924 · Cited by 6
“Nonetheless, tumor spheroids showed greater sensitivity to the compounds in dynamic conditions compared to static ones, likely due to enhanced drug diffusion into the spheroids (Astolfi et al. 2016; Eduati et al. 2018).”
Tokuoka, Y., Kondo, K., Nakaigawa, N., & Ishida, T. (2021) · Micromachines · doi:10.3390/mi12121482 · Cited by 6
“Additionally, highthroughput microfluidic devices have been used to culture some cubic and disk-shaped dissected tissues and examined multiple concentrations of drugs [28,29].”
BackgroundRecent advances on cancer-on-chip models: Development of 3D tumors and tumor microenvironment
Moghimi, N., Hosseini, S. A., Poudineh, M., & Kohandel, M. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00238 · Cited by 7
Parsian, M., Mutlu, P., Yıldırım, E., Ildiz, C., Özen, C., & Gündüz, U. (2022) · Biomicrofluidics · doi:10.1063/5.0087532 · Cited by 5
Wu, Z., Zeng, B., Seah, D. H., Ng, I. Z. R., Ding, R. H., Zhang, T., Kalaichelvan, M., You, R., & Fong, E. L. S. (2025) · Advanced Materials · doi:10.1002/adma.202512252 · Cited by 5
Shetty, S., Kumar, N. A. N., Kabekkodu, S. P., & Chakrabarty, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189627 · Cited by 6
Sibbitts, J., Pietro, L. D., Privitera, A., Cardaci, V., Maugeri, S., Camarda, M., & Caruso, G. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673298382240307040239 · Cited by 6
Monajjemi, M., & Mollaamin, F. (2024) · Sensor Review · doi:10.1108/sr-03-2024-0211 · Cited by 5
Kazempour, H., Teymouri, F., Khatami, M., & Hosseini, S. N. (2024) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2024.112960 · Cited by 4
St‐Georges‐Robillard, A., Masse, M., Kendall‐Dupont, J., Strupler, M., Patra, B., Jermyn, M., Mes‐Masson, A., Leblond, F., & Gervais, T. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2211159 · Cited by 4
Self-citationZhang, J., Sun, M., Zhang, F., Xuanyuan, T., Liu, X., Yu, D., & Liu, W. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501105 · Cited by 5
Kennedy, D. G., Zhao, W., Chern, T. L., Yang, M., Acosta, N., Arumugam, S., Upadhyayula, P. S., Furnari, J. L., Dovas, A., Bruce, J. N., et al. (2026) · Lab on a Chip · doi:10.1039/d5lc01105a · Cited by 3
Investigation of tumour environments through advancements in microtechnology and nanotechnology
Liu, Z., Fan, Y. L., Cui, M., Wang, X., & Zhao, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117230 · Cited by 4
Modern Approaches to Testing Drug Sensitivity of Patients’ Tumors (Review)
Николаевна, Д. И., Shirmanova, M. V., Kuznetsova, D. S., Lukina, M. M., & Вадимовна, З. Е. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.4.11 · Cited by 3
“In this case, tissue preparation includes bioptate mechanic fragmentation, which, however, can cause local tissue damage, though preserving an immunological profile [71, 72].”
BackgroundMicrofluidics for drug delivery systems
Aceves-Serrano, L. G., Ordaz-Martinez, K. A., Vázquez-Piñón, M., & Hwang, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816200-2.00002-5 · Cited by 3
mHealth-Based Microfluidic Lab-on-a-Chip for International Health Security
Baig, M. A. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90283 · Cited by 4
Current Applications of Organ-on-a-Chip: A Step Closer to Personalized Medicine
Victorious, A. P. (2022) · BIO Integration · doi:10.15212/bioi-2022-0027 · Cited by 4
“This platform has been used to examine micro-dissected tissue viability through confocal microscopy and flow cytometry, thereby yielding data on chemosensitivity tests and therapeutic response [70].”
MethodHorowitz, L. F., Rodríguez‐Mias, R. A., Chan, M., Zhu, S., Tang, Y., Locke, A., Gottshall, N. R., Stepanov, I., Stiles, C., Yeung, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.22.586189 · Cited by 3
“The Gervais group 24,27 prepared ~420 µm-diam. cylindrical µDTs by punching cores from patient-derived xenograft tumor slices followed by manual loading into microchannels with traps.”
Yadav, V. K., Ganguly, P., Das, S., Mishra, P., & Mallick, D. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11809 · Cited by 2
Arellano, J. A., Howell, T. A., Gammon, J., Cho, S., Janat-Amsbury, M. M., & Gale, B. K. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0166-3 · Cited by 2
A simple technique to design microfluidic devices for system integration
Yang, M. X., Wang, B. C., Hu, X., & Wong, H. ‐. P. (2017) · Analytical Methods · doi:10.1039/c7ay02177a · Cited by 2
Cancer stem cell enrichment in in vitro models: Techniques, insights, and applications
Ranjbar-Niavol, F., Barisam, M., Khosravi, A., Kashaninejad, N., Zarrabi, A., & Vosough, M. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217966 · Cited by 1
Hut, M., Clément, F., Tubbs, E., Caullet, P., Armanet, M., Domet, T., Bouzakri, K., Bietiger, W., Navarro, F. P., Fouillet, Y., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/ae2a72 · Cited by 1
“This design choice aligns with observations from other organ-on-chip platforms (e.g. tumor-on-chip [32], pancreas-on-chip [33]), where integration improves standardization and reproducibility.”
Patient-Specific Tumor Microenvironment Models
Lee, J. W., Kim, J., Shin, Y., Chi, B. H., Kim, J. H., & Choi, S. Y. (2021) · Journal of Urologic Oncology · doi:10.22465/kjuo.2021.19.4.197 · Cited by 1
Hidden in Plain Sight: The History, Science, and Engineering of Microfluidic Technology
Folch, A. (2022) · The MIT Press eBooks · doi:10.7551/mitpress/14236.001.0001 · Cited by 3
Microfluidics and Cancer Treatment: Emerging Concept of Biomedical Engineering
Tawade, P. V., & Tondapurkar, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_15 · Cited by 2
A 96-WELL VALVED MICROFLUIDIC DEVICE FOR TESTING OF LIVE INTACT TUMOR CUBOIDSPreprint
Lockhart, E. J., Horowitz, L. F., Lim, C., Nguyen, T., Mehrabi, M., Gujral, T. S., & Folch, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.07.499178 · Cited by 1
Development of Digital Microfluidics Platform for 2D and 3D Chemosensitivity Assays
Situ, H. (2017) · TSpace (University of Toronto)
Cell Death Analysis in Cancer Spheroids from a Microfluidic Device
Lafontaine, J., Refet-Mollof, E., Najyb, O., Gervais, T., & Wong, P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2553-8_2
Self-citationMonterosso, M. E. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.236375
Capillary Imbibition in a Diverging Flexible Channel
Boudina, M., & Elfring, G. J. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c01488
“This effortless method is commonly utilized by the microfluidics community to design circuits for fast and simultaneous reagent delivery [3], enzyme deposition [4] or micro-dissected tissue manipulation [5].”
MethodThe journey from bench to bedside—it takes a science village
Mes‐Masson, A. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0075
Self-citationDesign patterns of tumor-on-chips utilizing fluidic devices and their latest trends
Mori, N., & Kida, Y. S. (2024) · Drug Delivery System · doi:10.2745/dds.39.184
Saikia, T., Khanam, A., Ahmed, N., Bharali, A., Kalita, T., Rajak, P., Sahu, B. P., & Patowary, L. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947341257241018150125
Importance of microfluidics in cancer modeling
Suryavanshi, P., Dharwad, P., & Bodas, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95533-1.00010-2
Boudhraa, Z., Tian, X., Gam, R., Ritch, S. J., Kendall‐Dupont, J., Carmona, E., Provencher, D. M., Wu, J. H., & Mes‐Masson, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.02.641080
Self-citationBIOPRINTING OF MICRODISSECTED TUMOR “CUBOIDS” IN HYDROGELSPreprint
Bansal, A. M., Horowitz, L. F., Yeung, M., Gujral, T. S., & Folch, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.05.671932
Enhancing the cryopreservation of ex vivo 3D tumor models using vitrification strategiesPreprint
Brasseur, T., Page, G. E. L., St‐Georges‐Robillard, A., Mes‐Masson, A., & Gervais, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.01.679784
Self-citationUse of microfluidic “chip” devices for assessing the effect of radiation on 3D cell culture models
Chermat, R., Refet-Mollof, E., Ziaee, M., Lafontaine, J., Gervais, T., & Wong, P. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.09.003
Self-citationMehta, V., Vilikkathala Sudhakaran, S., Nellore, V., Madduri, S., & Rath, S. N. (2024) · Figshare · doi:10.6084/m9.figshare.26736153
Revisió bibliogràfica del desenvolupament de fàrmacs amb l'ajuda dels òrgan on a chip
Cañellas Solé, A. (2021) · Rovira & Virgili repository
Analyse automatique d'images histopathologiques de tissus tumoraux micro-disséqués
Lesec, C. (2022) · PolyPublie (École Polytechnique de Montréal)
Moulage par injection comme méthode de production de puces microfluidiques en PDMS
Filion, R. (2024) · PolyPublie (École Polytechnique de Montréal)
He, Y., Luo, Y., Chen, L., Wang, Y., Liu, B., Sun, M., Gong, W., Tian, X., Guo, L., Zhang, Q., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71560
“Specifically, organoid models and MDTs on a chip are ex vivo 3D models of drug testing for personalized drug screening [25, 37].”
Développement, validation et caractérisation d’un modèle ex vivo de peau humaine perfusé : FlowSkin
Raude, E. (2020) · theses.fr (ABES) · doi:10.70675/6f99a6b5z1801z427fzbe7bzd4a755d78038 · Cited by 2
Quintard, C. (2022) · theses.fr (ABES) · doi:10.70675/3030f258ze226z4f01za0f5z2079b9c601e5 · Cited by 2
Hypoxia-on-chip : from technological developments to biological applications
Bouquerel, C. (2023) · theses.fr (ABES) · doi:10.70675/d7d58b5dzd927z4235z8c54z8dbb6fd4757e · Cited by 1
Molecular imaging for nano-theranostics : Raman spectroscopy approach
Alaouta, C. (2024) · theses.fr (ABES) · doi:10.70675/90173e46zdf1dz4845z97f6z13cbe351311f
Qin, X., Zhao, Y., Wu, Y., Efelis, A., Paul, R., Islam, K., Marquez, C. S., Liu, Y., & Liu, Y. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01908
Apoptosis execution is spatially regulated
Milivojević, N. N., Mirić, A. N., Djukic, T. R., Petrović, I., Kesić, A., Jurišić, V., Dragačević, L., Živanović, M., & Filipović, N. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02385-0
“3D), which is consistent with the heterogeneous oxygen and nutrient profiles previously reported for perfused microfluidic 3D cultures [26 – 28 ].”
Microfluidic Tissue Array Platform for Personalized Drug Screening Using Tumor Explants or BiopsiesPreprint
Ahmed, A. H. R., Shao, H., Colón-Cartagena, L., Wang, L., Jiang, X., Pareja, F. G., Chandarlapaty, S., & Wang, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735821
“…media formulations[37], (2) standard cultureware placed on moving platforms for flow[4,19,38], (3) microfluidic systems for tissue trapping[20,39], (4) microfluidic systems with perfusion along a tissue edge[20,40], (4) macrofluidic/microfluidic systems of modified or custom cultureware…”
Time-dependent cytokine landscapes in an ex vivo microfluidic glioblastoma platform
Moursi, A., Barry, A., Feugere, L., Iles, A., Scott, I., Achawal, S., Rajaraman, C., Beltrán-Álvarez, P., & Greenman, J. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04486-w
“Microfluidic systems have been applied to a wide range of human tissues, including ovarian [11], lung [12], rectal [13], thyroid [14], head and neck [15], and brain [16].”
YILDIRIM, S., Gómez-Salgado, J. C., Khoury-Moreno, L. E., & Özden, Ö. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090914
“Drug resistance observed in 3D culture systems is driven by multi-layered molecular mechanisms that develop under the influence of the biochemical and physical conditions created by the tumor microenvironment [82,83].”
Ziaee, M., Lafontaine, J., Said, B. I., Kamal, K., Tsoi, K. M., Rodier, F., Gervais, T., & Wong, P. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71792
“If cultured properly, the latter models can preserve the integrity of the tumor cellular and architectural components and have the potential to serve as patient-specific models to predict patient treatment response [8, 10, 11].”
Self-citation
Metadata
- Authors
- Astolfi, M., Péant, B., Lateef, M. A., Rousset, N., Kendall-Dupont, J., Carmona, E., Monet, F., Saad, F., Provencher, D., Mes-Masson, A.-M., & Gervais, T.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Polytechnique Montréal (CA)
- Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM)
- Corresponding author
- Gervais, T.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2016
- Volume
- 16
- Issue
- 2
- Pages
- 312-325
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2185644008
- Cited by
- 182
- References
- 52
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 23 · 2023: 15 · 2022: 26 · 2021: 19 · 2020: 24 · 2019: 20 · 2018: 12 · 2017: 15 · 2016: 5
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- PolyPublie (École Polytechnique de Montréal) (submittedVersion)
- Funders
- Prostate Cancer Canada
- Canadian Cancer Society Research Institute
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ex vivo drug testing, precision oncology, chemosensitivity testing, tissue viability, metabolite transport, xenograft mouse model, ovarian cancer, prostate cancer, benign prostatic hyperplasia, patient-derived tissue, tumor spheroids
- MeSH terms
- Animals, Antineoplastic Agents, Drug Evaluation, Preclinical, Flow Cytometry, Humans, Neoplasms, Microscopy, Confocal, Microdissection, Tissue Culture Techniques, Mice, Lab-On-A-Chip Devices, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.